PTAB denies Celltrion’s patent challenge against Genentech
07-03-2017
bee32 / iStockphoto.com
The Patent Trial and Appeal Board (PTAB) has agreed to rehear an inter partes review (IPR) filed by Hospira, a company now owned by Pfizer.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Patent Trial and Appeal Board, PTAB, inter partes review, IPR, Genentech, Hospira, Pfizer, trastuzumab, Herceptin